EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Stakeholder-informed pre-implementation refinement of a pharmacy-led pre-exposure prophylaxis (PrEP) service delivery model in Malaysia

Yan Nee Gan iD, Sin How Lim, Frederick L Altice iD, Sharifah Khadijah Syed Razif, Mariani Ahmad Nizaruddin iD, Reena Rajasuriar, Sazali Basri iD, Joselyn Pang, Andrew Yap, Iskandar Azwa, Rafdzah Zaki

PLOS One · 2026

DOI: 10.1371/journal.pone.0357920 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS One, 2026. Verfasst von Yan Nee Gan und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Social and Preventive Medicine, Faculty of Medicine, Universiti Malaya, Kuala Lumpur, Malaysia. Hauptthemen laut MEDLINE: Pre-Exposure Prophylaxis, HIV Infections, Stakeholder Participation, Anti-HIV Agents. Die Arbeit nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: FIC NIH HHS, World Health Organization, Fogarty International Center.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

In 2024, only 3,451 individuals accessed free oral HIV pre-exposure prophylaxis (PrEP) at government clinics in Malaysia, despite an estimated 354,000 key population members who could benefit from PrEP. To inform pre-implementation refinement of a pharmacy-led PrEP service delivery model, we explored stakeholder perspectives on implementing the model within private community pharmacies in Malaysia. Materials and methods A one-day stakeholder consultation was conducted in April 2023 in Kuala Lumpur with 28 stakeholders representing community pharmacies, professional societies, telemedicine providers, non-governmental organizations (NGOs), and HIV implementation science researchers. The meeting began with a review of preliminary findings from formative qualitative research involving key populations, community pharmacists, and PrEP prescribers. Through facilitated discussions, stakeholders identified short- and long-term solutions to implementation barriers. Stakeholder inputs from discussions and structured worksheets were synthesized descriptively to identify recurring implementation considerations that informed refinement of the pilot model.

Results

Key implementation considerations included enhancing awareness and demand generation, ensuring privacy, confidentiality, and affordability, integrating HIV self-testing, using digital checklist-based assessments, simplifying laboratory testing requirements, developing practical workflows supported by a reference guide, strengthening pharmacist training, and fostering cross-sector collaboration. Identified training needs included PrEP fundamentals, eligibility assessment for initiation and continuation, referral procedures, and scenario-based learning. Key competencies included knowledge of HIV and sexually transmitted infections, risk assessment, professional conduct, and person-centered communication. Six study sites were selected, with preparation requirements including HIV self-test kits, PrEP medications, informational materials, trained pharmacists, telemedicine subscriptions, and nearby referral clinics. The consultation informed refinements to the implementation plan.

Conclusions

This stakeholder consultation informed refinement of a pharmacy-led PrEP service delivery model for pilot implementation in Malaysia and identified practical implementation considerations related to privacy, affordability, HIV self-testing, physician-pharmacist coordination, training, and referral systems. The findings may inform future implementation planning for similar urban, private-sector PrEP delivery models.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pre-Exposure ProphylaxisHIV InfectionsStakeholder ParticipationAnti-HIV AgentsCommunity Pharmacy ServicesMalaysiaHumansPharmaciesPharmacists

Substanzen

Anti-HIV Agents

Autor:innen und Institutionen

  • Department of Social and Preventive Medicine, Faculty of Medicine, Universiti Malaya, Kuala Lumpur, Malaysia.
  • Malaysian Health Technology Assessment Section (MaHTAS), Ministry of Health, Putrajaya, Malaysia.
  • Centre of Excellence for Research in Infectious Diseases and AIDS (CERiA), Universiti Malaya, Kuala Lumpur, Malaysia.
  • Section of Infectious Disease, Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut, United States of America.
  • Division of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, Connecticut, United States of America.
  • Center for Interdisciplinary Research on AIDS (CIRA), Yale University, New Haven, Connecticut, United States of America.

ORCID-Profile: Yan Nee Gan, Frederick L Altice, Mariani Ahmad Nizaruddin, Sazali Basri

Förderung

  • FIC NIH HHS
  • World Health Organization
  • Fogarty International Center

Zitieren

APA

Gan, Y. N., Lim, S. H., Altice, F. L., Syed Razif, S. K., Ahmad Nizaruddin, M., Rajasuriar, R., Basri, S., Pang, J., Yap, A., Azwa, I., & Zaki, R. (2026). Stakeholder-informed pre-implementation refinement of a pharmacy-led pre-exposure prophylaxis (PrEP) service delivery model in Malaysia. PLOS One. https://doi.org/10.1371/journal.pone.0357920

Vancouver

Gan YN, Lim SH, Altice FL, Syed Razif SK, Ahmad Nizaruddin M, Rajasuriar R, et al. Stakeholder-informed pre-implementation refinement of a pharmacy-led pre-exposure prophylaxis (PrEP) service delivery model in Malaysia. PLOS One. 2026. doi:10.1371/journal.pone.0357920

BibTeX
@article{Gan2026,
  author = {Gan, Yan Nee and Lim, Sin How and Altice, Frederick L and Syed Razif, Sharifah Khadijah and Ahmad Nizaruddin, Mariani and Rajasuriar, Reena and Basri, Sazali and Pang, Joselyn and Yap, Andrew and Azwa, Iskandar and Zaki, Rafdzah},
  title = {Stakeholder-informed pre-implementation refinement of a pharmacy-led pre-exposure prophylaxis (PrEP) service delivery model in Malaysia},
  journal = {PLOS One},
  year = {2026},
  doi = {10.1371/journal.pone.0357920}
}
Kostenlos starten →